[artículo] 
inPsychiatric Clinics of North America > Año 2001 - Vol. 24 No. 4 (Diciembre) . - pp. 783-803

Título :	Pharmacotherapy of social anxiety disorder at the turn of the millennium
Tipo de documento:	texto impreso
Autores:	Michael Van Ameringen, Autor ; Catherine Mancini, Autor
Fecha de publicación:	2020
Artículo en la página:	pp. 783-803
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Beta-antagonistas adrenérgicos, Ansiolíticos, Anticonvulsivos, Antidepresivos, Trastornos de ansiedad, Trastornos fóbicos.
Resumen:	Over the past 21 years since the birth of SP into the diagnostic nomenclature, there have been significant gains in knowledge about effective pharmacologic and psychotherapeutic treatments. The SSRIs have emerged as the first-line pharmacologic treatment, although good evidence shows efficacy of benzodiazepines; MAOIs; and anticonvulsant agents, such as gabapentin and pregabalin.
Link:	./index.php?lvl=notice_display&id=24855

[artículo] Pharmacotherapy of social anxiety disorder at the turn of the millennium [texto impreso] / Michael Van Ameringen, Autor ; Catherine Mancini, Autor . - 2020 . - pp. 783-803.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2001 - Vol. 24 No. 4 (Diciembre) . - pp. 783-803

Palabras clave:	Beta-antagonistas adrenérgicos, Ansiolíticos, Anticonvulsivos, Antidepresivos, Trastornos de ansiedad, Trastornos fóbicos.
Resumen:	Over the past 21 years since the birth of SP into the diagnostic nomenclature, there have been significant gains in knowledge about effective pharmacologic and psychotherapeutic treatments. The SSRIs have emerged as the first-line pharmacologic treatment, although good evidence shows efficacy of benzodiazepines; MAOIs; and anticonvulsant agents, such as gabapentin and pregabalin.
Link:	./index.php?lvl=notice_display&id=24855